Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of probiotics on salivary microflora and dental biofilm
DRKS00017822Phase 4Completed
- Sponsor
- Klinik für Parodontologie und peri-implantäre Erkrankungen, Philipps-Universität Marburg
- Start
- Sep 2019
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Symbioflor Bronchoprotect, Lactobacillus casei DN-114001 and Lactobacillus rhamnosus GG in dental biofilm (3 arms), sponsored by Klinik für Parodontologie und peri-implantäre Erkrankungen, Philipps-Universität Marburg. Primary endpoints: Change in salivary microflora composition and Integration of probiotics into in situ dental biofilm. Started Sep 2019; status: completed.
02
Drugs
Symbioflor BronchoprotectLactobacillus casei DN-114001Lactobacillus rhamnosus GG
03
Conditions
dental biofilm
Beyond the preview
Go deeper on DRKS00017822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017822.